These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 8475360)
21. Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials. Yap YG; Duong T; Bland M; Malik M; Torp-Pedersen C; Køber L; Connolly SJ; Marchant B; Camm J Eur Heart J; 2005 Jul; 26(14):1385-93. PubMed ID: 15914501 [TBL] [Abstract][Full Text] [Related]
22. [Long-term treatment with amiodarone]. Baedeker W; Goedel-Meinen L; Schmidt G; Hofmann M; Barthel P; Blömer H Z Kardiol; 1991 Feb; 80(2):158-66. PubMed ID: 1711739 [TBL] [Abstract][Full Text] [Related]
23. Low-dose amiodarone in severe chronic heart failure. Biswas A; Dey SK; Banerjee AK; Roy S; Biswas PK; Chowdhury GK; Khan AK; Mitra KK; Chatterjee SS; Maity AK Indian Heart J; 1996; 48(4):361-4. PubMed ID: 8908821 [TBL] [Abstract][Full Text] [Related]
24. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS). Burkart F; Pfisterer M; Kiowski W; Follath F; Burckhardt D J Am Coll Cardiol; 1990 Dec; 16(7):1711-8. PubMed ID: 2254558 [TBL] [Abstract][Full Text] [Related]
25. Predictors of sudden cardiac death in never previously treated patients with essential hypertension: long-term follow-up. Saadeh AM; Jones JV J Hum Hypertens; 2001 Oct; 15(10):677-80. PubMed ID: 11607796 [TBL] [Abstract][Full Text] [Related]
26. [Multicenter clinical trial on the prevention of sudden death after myocardial infarction by the use of anti-arrhythmia agents. Investigator Group of the Spanish Study on Sudden Death]. Rev Esp Cardiol; 1989 Feb; 42(2):77-83. PubMed ID: 2675221 [TBL] [Abstract][Full Text] [Related]
27. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure. Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711 [TBL] [Abstract][Full Text] [Related]
28. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Julian DG; Camm AJ; Frangin G; Janse MJ; Munoz A; Schwartz PJ; Simon P Lancet; 1997 Mar; 349(9053):667-74. PubMed ID: 9078197 [TBL] [Abstract][Full Text] [Related]
29. Amiodarone in high-risk post-infarction patients, Lessons from EMIAT and CAMIAT. European Myocardial Infarct Amiodarone Trial and Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. Gambhir DS Indian Heart J; 1996; 48(4):339-41. PubMed ID: 8908817 [No Abstract] [Full Text] [Related]
30. Long term efficacy and toxicity of amiodarone in the treatment of refractory cardiac arrhythmias. Primeau R; Agha A; Giorgi C; Shenasa M; Nadeau R Can J Cardiol; 1989 Mar; 5(2):98-104. PubMed ID: 2706579 [TBL] [Abstract][Full Text] [Related]
31. Long-term amiodarone therapy and the risk of complications after cardiac surgery: results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT). Crystal E; Kahn S; Roberts R; Thorpe K; Gent M; Cairns JA; Dorian P; Connolly SJ J Thorac Cardiovasc Surg; 2003 Mar; 125(3):633-7. PubMed ID: 12658206 [TBL] [Abstract][Full Text] [Related]
32. QT dispersion as a predictor of long-term mortality in patients with acute myocardial infarction and clinical evidence of heart failure. Spargias KS; Lindsay SJ; Kawar GI; Greenwood DC; Cowan JC; Ball SG; Hall AS Eur Heart J; 1999 Aug; 20(16):1158-65. PubMed ID: 10448024 [TBL] [Abstract][Full Text] [Related]
33. Arrhythmias in heart failure--the role of amiodarone. Dargie HJ; Cleland JG Clin Cardiol; 1988 Mar; 11(3 Suppl 2):II26-30. PubMed ID: 3271192 [TBL] [Abstract][Full Text] [Related]
34. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators. Cleland JG; Erhardt L; Murray G; Hall AS; Ball SG Eur Heart J; 1997 Jan; 18(1):41-51. PubMed ID: 9049514 [TBL] [Abstract][Full Text] [Related]
35. Long-term outcome of coronary artery bypass grafting in patients with left ventricular dysfunction. Nardi P; Pellegrino A; Scafuri A; Colella D; Bassano C; Polisca P; Chiariello L Ann Thorac Surg; 2009 May; 87(5):1401-7. PubMed ID: 19379873 [TBL] [Abstract][Full Text] [Related]
37. Amiodarone versus Implantable Defibrillator (AMIOVIRT): background, rationale, design, methods, results and implications. Wijetunga M; Strickberger SA; Card Electrophysiol Rev; 2003 Dec; 7(4):452-6. PubMed ID: 15071274 [TBL] [Abstract][Full Text] [Related]
38. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591 [TBL] [Abstract][Full Text] [Related]
39. [Short-term and long-term outcome of left heart function after cardioverter defibrillator implantation]. Takeichi K; Kasanuki H; Ohnishi S; Endoh Y; Hosoda S J Cardiol; 1996 Nov; 28(5):277-86. PubMed ID: 8953401 [TBL] [Abstract][Full Text] [Related]
40. [The heart rate variability indices and the circadian rhythm of the hourly heart rate: 2 prognostic indicators of mortality and malignant ventricular arrhythmias in patients with a myocardial infarct]. Curione M; Lucia P; Proietti E; Cedrone L; Bernardini F; Trappolini M; Di Giovine M; Puletti M; Cugini P Cardiologia; 1996 Dec; 41(12):1175-82. PubMed ID: 9064214 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]